Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036311 | SCV000059963 | likely benign | not specified | 2009-12-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000036311 | SCV000209153 | benign | not specified | 2014-09-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000866578 | SCV001007692 | likely benign | Hypertrophic cardiomyopathy | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001192354 | SCV001360402 | likely benign | Cardiomyopathy | 2020-02-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003298060 | SCV003990497 | likely benign | Cardiovascular phenotype | 2023-05-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000866578 | SCV004821904 | likely benign | Hypertrophic cardiomyopathy | 2023-08-15 | criteria provided, single submitter | clinical testing |